BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15730597)

  • 1. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children.
    Stryjewski GR; Nylen ES; Bell MJ; Snider RH; Becker KL; Wu A; Lawlor C; Dalton H
    Pediatr Crit Care Med; 2005 Mar; 6(2):129-35. PubMed ID: 15730597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer.
    Urbonas V; Eidukaitė A; Tamulienė I
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):122-7. PubMed ID: 22367386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.
    Kitanovski L; Jazbec J; Hojker S; Gubina M; Derganc M
    Eur J Clin Microbiol Infect Dis; 2006 Jun; 25(6):413-5. PubMed ID: 16767494
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.
    Hatzistilianou M; Rekliti A; Athanassiadou F; Catriu D
    Inflamm Res; 2010 May; 59(5):339-47. PubMed ID: 19806318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
    Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
    Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
    Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial.
    Santolaya ME; Alvarez AM; Aviles CL; Becker A; King A; Mosso C; O'Ryan M; Paya E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    Pediatr Infect Dis J; 2008 Jun; 27(6):538-43. PubMed ID: 18458649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia.
    Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D
    Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial procalcitonin levels to detect bacteremia in febrile neutropenia.
    Reitman AJ; Pisk RM; Gates JV; Ozeran JD
    Clin Pediatr (Phila); 2012 Dec; 51(12):1175-83. PubMed ID: 23034950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children.
    Lodahl D; Schrøder H
    Dan Med Bull; 2011 Mar; 58(3):A4233. PubMed ID: 21371399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
    van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
    Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.
    Müller B; Becker KL; Schächinger H; Rickenbacher PR; Huber PR; Zimmerli W; Ritz R
    Crit Care Med; 2000 Apr; 28(4):977-83. PubMed ID: 10809269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients].
    Robinson JO; Calandra T; Marchetti O
    Rev Med Suisse; 2005 Mar; 1(13):878-82, 885-6. PubMed ID: 15895930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
    Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
    Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
    de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
    Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.